321 related articles for article (PubMed ID: 17494842)
1. Hepatocellular carcinoma with internal mammary artery supply: feasibility and efficacy of transarterial chemoembolization and factors affecting patient prognosis.
Kim HC; Chung JW; Choi SH; Yoon JH; Lee HS; Jae HJ; Lee W; Park JH
J Vasc Interv Radiol; 2007 May; 18(5):611-9; quiz 620. PubMed ID: 17494842
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
[TBL] [Abstract][Full Text] [Related]
3. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
[TBL] [Abstract][Full Text] [Related]
4. Chemoembolization for the treatment of large hepatocellular carcinoma.
Miyayama S; Yamashiro M; Okuda M; Yoshie Y; Sugimori N; Igarashi S; Nakashima Y; Notsumata K; Toya D; Tanaka N; Mitsui T; Matsui O
J Vasc Interv Radiol; 2010 Aug; 21(8):1226-34. PubMed ID: 20598571
[TBL] [Abstract][Full Text] [Related]
5. The march of extrahepatic collaterals: analysis of blood supply to hepatocellular carcinoma located in the bare area of the liver after chemoembolization.
Miyayama S; Yamashiro M; Okuda M; Yoshie Y; Nakashima Y; Ikeno H; Orito N; Matsui O
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):513-22. PubMed ID: 19756862
[TBL] [Abstract][Full Text] [Related]
6. Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival.
Grieco A; Marcoccia S; Miele L; Marmiroli L; Caminiti G; Ragazzoni E; Cotroneo AR; Cefaro GA; Rapaccini GL; Gasbarrini G
Hepatogastroenterology; 2003; 50(49):207-12. PubMed ID: 12630024
[TBL] [Abstract][Full Text] [Related]
7. Transarterial chemoembolization of a colic branch of the superior mesenteric artery in patients with unresectable hepatocellular carcinoma.
Kim HC; Chung JW; An S; Seong NJ; Son KR; Jae HJ; Park JH
J Vasc Interv Radiol; 2011 Jan; 22(1):47-54. PubMed ID: 21195900
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter arterial chemoembolization for hepatocellular carcinoma fed by the reconstructed inferior phrenic artery: anatomical and technical analysis.
Miyayama S; Matsui O; Taki K; Minami T; Ito C; Shinmura R; Takamatsu S; Kobayashi M; Notsumata K; Toya D; Tanaka N; Kozaka K
J Vasc Interv Radiol; 2004 Aug; 15(8):815-23. PubMed ID: 15297585
[TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization for hepatocellular carcinoma: significance of extrahepatic collateral supply.
Paul SB; Gamanagatti SR; Mukund A; Abbas SZ; Acharya SK
Indian J Cancer; 2011; 48(3):339-44. PubMed ID: 21921335
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic factors for survival following transarterial chemoembolization in advanced hepatocellular carcinoma].
Alvarez R; Bañares R; Echenagusía A; Carneros JA; Santos L; Simó G; Camúñez F
Gastroenterol Hepatol; 2000 Apr; 23(4):153-8. PubMed ID: 10863854
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma: assessment of response to transarterial chemoembolization with image subtraction.
Kim S; Mannelli L; Hajdu CH; Babb JS; Clark TW; Hecht EM; Taouli B
J Magn Reson Imaging; 2010 Feb; 31(2):348-55. PubMed ID: 20099348
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma invading the main portal vein: treatment with transcatheter arterial chemoembolization and portal vein stenting.
Zhang XB; Wang JH; Yan ZP; Qian S; Liu R
Cardiovasc Intervent Radiol; 2009 Jan; 32(1):52-61. PubMed ID: 18931871
[TBL] [Abstract][Full Text] [Related]
13. Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis.
Pietrosi G; Miraglia R; Luca A; Vizzini GB; Fili' D; Riccardo V; D'Antoni A; Petridis I; Maruzzelli L; Biondo D; Gridelli B
J Vasc Interv Radiol; 2009 Jul; 20(7):896-902. PubMed ID: 19497762
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Doxorubicin Drug-Eluting Embolic Chemoembolization of Hepatocellular Carcinoma Supplied by Extrahepatic Collateral Arteries.
Lokken RP; Fidelman N; Kolli KP; Kerlan RK
J Vasc Interv Radiol; 2016 Nov; 27(11):1698-1704. PubMed ID: 27397617
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead.
Malagari K; Alexopoulou E; Chatzimichail K; Hall B; Koskinas J; Ryan S; Gallardo E; Kelekis A; Gouliamos A; Kelekis D
Abdom Imaging; 2008; 33(5):512-9. PubMed ID: 17938995
[TBL] [Abstract][Full Text] [Related]
16. Clinico-roentogenologic findings in hepatocellular carcinoma fed by the right inferior phrenic artery at the initial chemoembolization.
Kimura S; Okazaki M; Higashihara H; Haruno M; Nozaki Y; Urakawa H; Kora S; Shinagawa Y; Nonokuma M
Hepatogastroenterology; 2009; 56(89):191-8. PubMed ID: 19453056
[TBL] [Abstract][Full Text] [Related]
17. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis.
Georgiades CS; Hong K; D'Angelo M; Geschwind JF
J Vasc Interv Radiol; 2005 Dec; 16(12):1653-9. PubMed ID: 16371532
[TBL] [Abstract][Full Text] [Related]
19. Chemoembolization in patients at high risk: results and complications.
Kiely JM; Rilling WS; Touzios JG; Hieb RA; Franco J; Saeian K; Quebbeman EJ; Pitt HA
J Vasc Interv Radiol; 2006 Jan; 17(1):47-53. PubMed ID: 16415132
[TBL] [Abstract][Full Text] [Related]
20. Degradable starch microspheres versus ethiodol and doxorubicin in transarterial chemoembolization of hepatocellular carcinoma.
Niessen C; Unterpaintner E; Goessmann H; Schlitt HJ; Mueller-Schilling M; Wohlgemuth WA; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2014 Feb; 25(2):240-7. PubMed ID: 24291001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
